HomeProductos y ServiciosNotasMisión y EstrategiaSuscripciónContáctenos  
 Farmoguía CHT Personal Care  Guía de Proveedores   ExpoFelow Encuentros de Negocios  
    
      
 

Novedades

Sanofi-Aventis Argentina entra al segmento OTC

18 de mayo de 2009


Con el objetivo de ingresar en el mercado de los medicamentos de venta libre, Sanofi-Aventis Argentina compró al laboratorio argentino Gramon 18 de sus marcas emblemáticas. Adermicina, Bronquisedan, Irix, Ratisalil, No Tos y Biogrip son las más importantes...


Más Información.

Se concretó la primera exportación de vacunas contra la aftosa a Estados Unidos

18 de mayo de 2009

Biogénesis Bagó anuncia primera exportación de gran escala de antígenos concentrados hacia el Banco Norteamericano de Antígeno y Vacunas contra la Fiebre Aftosa...

Más Información.

Aumentaron un 27% las exportaciones de medicamentos

18 de mayo de 2009


Las exportaciones de medicamentos superaron los 161 millones de dólares en los primeros tres meses de este año, lo que representa un incremento del 27% respecto del mismo período del año anterior, de acuerdo con cifras oficiales.

Más Información.


BIOTECNOLOGIA

18 de mayo de 2009

Rise in sales for Millbrook. Millbrook Scientific Instruments, the designer and manufacturer of scientific instruments based in Blackburn has released a trading update for the year ended 31 March ahead of its full-year results. Total sales in the period rose to £2.87m from £2.5m a year earlier, with second-half sales at £1.6m up from £1.5m. The company said performance and order intake in the second half of the year, when the global economic downturn took hold remained satisfactory.

BioIndustry Association welcomes potential measures to support bioscience companies
The BioIndustry Association welcomed the introduction of a £750m Strategic Investment Fund for emerging technologies, including biotech, which was announced by the Chancellor of the Exchequer in the Budget on 22 April. The fund is designed to ‘promote research and development and harness commercially our world class science base’. This fund could make a significant contribution to supporting and building a successful and sustainable bioscience sector in the UK.

Funding boost benefits small to medium sized companies.
The Technology Strategy Board has made a commitment to reduce the cost to small and medium sized businesses (SME's) of its Knowledge Transfer Partnership (KTP) programme from 1st April for one year. The move has the full support of the other government organisations that are funding Knowledge Transfer Partnerships and will mean that companies will see an 8% fall in the amount that they are required to contribute to individual projects. It is hoped that this incentive will encourage SME's to take part in the KTP programme despite the uncertain financial climate.

Links recomendados
CLASIFARMA      FARMOGUIA     CHTGUIA     PHARMAFORO     PHARMATRAVEL
Cooperala     Capgen     Cilfa     Caeme     Capemvel     Clamevet     Caprove     Cofa     Colfarma
ANMAT    INAME     SENASA     AAQC     SAFYBI     FSFA     REMEDIAR     MDM
Copyright © 2008 - Felow dmg - Todos los derechos reservados Sitio realizado por Domo Solutions